Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 371 results for "pfizer"

British Researchers to Take Up Rare Trial for Lung Cancer
MedIndia

British Researchers to Take Up Rare Trial for Lung Cancer

In a novel feat, British researchers will test around 14 lung cancer drugs from AstraZeneca and Pfizer simultaneously within one trial. The idea is to find out medicines that can fight advanced lung cancer according to the genes of the patient. MedIndia, 19 hours ago

974 images for pfizer

1440 WNFL, 2 days ago
Jutia Group, 10 hours ago
Orlando Sentinel, 2 days ago
Lawyer Herald, 1 day ago
This Day Online, 3 days ago
Value Walk, 2 days ago
Jutia Group, 2 days ago
Business Week, 1 day ago
Philly.com, 2 days ago
Reuters, 2 days ago
Money Control

ASMI Welcomes Pfizer Australia As New Member

ASMI Welcomes Pfizer Australia As
 Noodls4 hours ago Pfizer jumps over 10% in two sessions  Business Standard1 month ago Pfizer surges on parent's restructuring  Business Standard1 month ago Pfizer announces internal corporate restructuring plan, stock soars 18%  Business Standard1 month ago
[x]  
Lawyer Herald

Pfizer Invites Public to Listen to Webcast of April 24 Annual Meeting of Shareholders

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 8:30 a.m. (Eastern Daylight Time) on Thursday, April 24. To access the webcast, visit our website at ...
 CNBC1 day ago Teva settles with Pfizer on generic Celebrex  Chain Drug Review1 day ago Teva settles generic Celebrex patent litigation with Pfizer  PharmaBiz1 day ago UPDATE 2-Teva settles patent suit with Pfizer over Celebrex  Reuters2 days ago
[x]  

Pfizer (PFE) Crosses Pivot Point Resistance at $30.23

Shares of Pfizer (NYSE:PFE) have bullishly opened above the pivot of $30.07 today and have reached the first resistance level of $30.23. Analysts will be watching for a cross of the next upside pivot targets of $30.37
 Individual.com2 days ago Pfizer (PFE) Breaks Through Resistance at $30.23  Individual.com2 days ago Pfizer (PFE) Trading Near $30.73 Resistance Level  Individual.com5 days ago
Financial Express

Pfizer Merger Unfair To Wyeth

Pfizer Merger Unfair To Wyeth
 Money Control3 days ago Proxy advisory company SES tells Wyeth investors to oppose Pfizer merger  Economic Times4 days ago Analysts divided on fairness of Pfizer-Wyeth deal  FirstWord Pharma3 days ago
The Manufacturer

Lung cancer trial will test personalised medicines

The pharmaceutical companies AstraZeneca and Pfizer are working with the charity Cancer Research UK on a £25million research project investigating personalised medicines for patients with advanced lung cancer. The National Drug Matrix trial will ...
 PJ Online2 days ago Cancer Research UK, Pfizer, AstraZeneca team up for lung cancer trial  Drug Discovery News1 day ago Cancer Research partners with AstraZeneca and Pfizer to create clinical trial for advanced lung cancer  News-Medical.Net2 days ago Personalised treatments to be trialed for lung cancer patients  The Manufacturer2 days ago
[x]  

Why this biotech is rushing in as big pharma exits

Pfizer CEO worries about ACA coverage Ian Read, Pfizer CEO, discusses the pricing and affordability of drugs in the U.S. Read also weighs in on insurance coverage under the Affordable Care Act. The company, and the field, got a big boost in ...
 CNBC2 days ago Video: Pfizer CEO worries about ACA coverage  NBCNews.com1 week ago
In-Pharmatechnologist

Acura pays Pfizer $2m to buy back anti-abuse tech and relaunch Oxecta drug

Acura has reacquired the rights to its opioid abuse-deterrent technology from Pfizer and is looking for pharma partners to relaunch its oxycodone HCL drug Oxecta. The immediate release analgesic drug Oxecta was co-developed by King ...
 In-Pharmatechnologist4 days ago Acura Pharmaceuticals, Inc. Walks Away From Pfizer Inc. Licensing Pact  BioSpace1 week ago Acura Pharma And Pfizer End Aversion Technology License  RTTNews.com1 week ago Acura Pharmaceuticals re-acquires rights to its AVERSION Technology from Pfizer  Individual.com1 week ago
[x]  
Financial Express

New kind of trial aims to speed cancer drug development

* AstraZeneca, Pfizer, UK charity link in multi-drug trial * Scope to test up to 14 drugs within same clinical study * Approach marks radical break with traditional trial design * Advances in genetic medicine allows remodelled trials * Could ...
 CNBC3 days ago AstraZeneca and Pfizer Collaborate on a New Oncology Trial Design  American Journal of Managed Care2 days ago One Of A Kind Trial To Test 14 AstraZeneca PLC, Pfizer Inc. Drugs At The Same Time  BioSpace2 days ago New kind of trial offers hope of cancer cure  Financial Express2 days ago
[x]  

Teva settles with Pfizer on arthritis treatment

Brand Celebrex has $2.2 billion in US sales in 2013, according to IMS data. Teva has received Tentative Approval from the US Food and Drug Administration (FDA) for all strengths of generic Celebrex, and believes that it is first-to-file on at ...
 Globes2 days ago BRIEF: Teva settles with Pfizer on arthritis treatment [Globes, Tel Aviv, Israel :: ]  BusinessWeek2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pfizer
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less